- £9.48m
- £9.37m
- -£2.19m
- 51
- 59
- 45
- 50
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.315 | 0.904 | 0.049 | 0.871 | 0.047 |
Prepaid Expenses | |||||
Total Current Assets | 0.317 | 0.913 | 0.071 | 0.883 | 0.058 |
Long Term Investments | |||||
Total Assets | 2.39 | 2.09 | 5.18 | 7.5 | 5.15 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Current Liabilities | 0.026 | 0.028 | 0.023 | 0.025 | 0.043 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.026 | 0.028 | 0.023 | 0.025 | 0.043 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 2.37 | 2.06 | 5.15 | 7.48 | 5.11 |
Total Liabilities & Shareholders' Equity | 2.39 | 2.09 | 5.18 | 7.5 | 5.15 |
Total Common Shares Outstanding |